REGISTER TO ATTEND
“How Coronavirus and Other Infections Trigger Neurologic, Psychiatric and Behavioral Disorders”
October's Special Presentation will be by Craig Shimasaki,
President & CEO, Moleculera Labs
Dr. Craig Shimasaki is a scientist, businessperson, and serial entrepreneur with over 31 years of biotechnology industry experience, starting his career at Genentech. He co-founded four companies and is President & CEO of Moleculera Labs, a University of Oklahoma spin-out company focused on autoimmune neurobiology clinical laboratory testing. His passion is to see acutely needed medical products become readily available for patients who need them. He has assisted professors, physicians and scientists in translating their ideas into commercial products. He an Adjunct Professor at the University of Oklahoma, Price School of Business and teaches biotechnology entrepreneurship.
Dr. Shimasaki is a co-inventor on several medical and diagnostic patents. His product development experience includes biologics, therapeutics, molecular diagnostics and medical devices, and he directed two CLIA Clinical Laboratories. He has led five clinical diagnostic tests through FDA approval and has been involved in raising over $60 million for these companies and participated in taking one company public. He has authored and edited two books “The Business of Bioscience: What Goes Into Making a Biotechnology Product” and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies”. He serves on several boards involved in entrepreneurial endeavors. Dr. Shimasaki received his BS in Biochemistry from University of California at Davis, his PhD in Molecular Biology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business.
Register to Attend